Loading the state's markets…
Loading the state's markets…
Medicare volume, surgeons and outlook for 51 device-driven procedures, CMS 2024
MedaRep names every surgeon in each market, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Dialysis access | 74 | 6,490−18%/yr | −18%/yr | 7.81.5× | 72% | 6,500 in 20300%/yr |
| Superficial venous ablation |
How the numbers are made · Every state · Compare two markets
Share of surgeons' claims in surgery centers and offices.
Today's surgeons with a 50%+ chance of no longer billing it here.
Share of the named cases done by the 10 busiest surgeons.
| 64 |
| 4,583−7.7%/yr |
| −7.7%/yr |
| 5.00.8× |
| 100% |
| 5,820 in 2030+4.1%/yr |
| Peripheral arterial intervention | 21 | 3,651−12%/yr | −12%/yr | 4.00.6× | 46% | 4,960 in 2030+5.3%/yr |
| Thrombectomy, IVC filters & venous stents | 9 | 1,269−2.2%/yr | −2.2%/yr | 1.50.9× | 9% | 1,580 in 2030+3.7%/yr |
| Carotid revascularization | 20 | 1,108−4.6%/yr | −4.6%/yr | 1.31.0× | 0% | 1,310 in 2030+2.8%/yr |
| Aortic endografts (EVAR/TEVAR) | 2 | 405−5.4%/yr | −5.4%/yr | 0.51.0× | 0% | 450 in 2030+1.8%/yr |
Share of the orthopedic, spine, extremity and wound cases CMS names by surgeon, by where the surgeon billed. Open a metro for its ranking.